Company / SG&A Expense
NeuroPace Inc SG&A Expense History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$17.4M
FY2025
5-year range
$17.4M / $54.5M
FY2021-FY2025
Trend
-68.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $51M to $17M over the past 2 years.
Based on SEC 10-K filings.
$17M in FY2025 with a 3-year CAGR of -23.5%.
Improved from $51M to $17M over the past 2 years.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- -23.5%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of -23.5%, indicating a declining trend.
- In FY2025, sg&a expense decreased 68.0% year-over-year.
- Peak sg&a expense was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score 0.67 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $17.4M | -68.0% |
| FY2024 | $54.5M | +6.2% |
| FY2023 | $51.3M | +31.8% |
| FY2022 | $39.0M | +41.0% |
| FY2021 | $27.6M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026